"/> Novus Biologicals™ Peptide bloquant d’anticorps NL… | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps NLRP1/NALP1

Réf. : BL-RE-044080Réf. fabricant : 18280496 0.05 mg
201,94 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
22861
Espèces
Human
Contenu et stockage
Store at -20 C. Avoid freeze-thaw cycles.
Formule
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)
This Peptide is Useful as a Blocking Peptide for NBP1-76656. For Further Blocking Peptide Related Protocol, Click Here .
Marque
Novus Biologicals

A blocking peptide containing 13 amino acids near the carboxy terminus of human NALP1.

Points forts

Source

Synthetic

(Accession #: AAG30288) The NLRP1/NALP1 Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-044080
Réf. fabricant18280496
Gene ID (Entrez)22861
EspècesHuman
Contenu et stockageStore at -20 C. Avoid freeze-thaw cycles.
FormulePBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NBP1-76656. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gèneCARD7SLEV1, Caspase recruitment domain-containing protein 7, CLR17.1, Death effector filament-forming ced-4-like apoptosis protein, DEFCAPVAMAS1, DKFZp586O1822, KIAA0926DEFCAP-L/S, NACHT, leucine rich repeat and PYD (pyrin domain) containing 1, NACHT, leucine rich repeat and PYD containing 1, NACHT, LRR and PYD containing protein 1, NACHT, LRR and PYD domains-containing protein 1, NACPP1044, NALP1caspase recruitment domain protein 7, NLR family, pyrin domain containing 1, Nucleotide-binding domain and caspase recruitment domain, nucleotide-binding oligomerization domain, leucine rich repeat and pyrin domaincontaining 1
Symbole de gène(s)NLRP1
Type de produitNLRP1/NALP1
Quantité0.05 mg
État réglementaireRUO - research use only
SourceSynthetic
Consigne13 amino acids near the carboxy terminus of human NALP1
Une question, une configuration particulière ?
Contactez-nous pour un devis.